|
|
|
|
||
Latest release from GBT:Global Blood Therapeutics announces publication of data from its Phase 1/2 study of voxelotor in sickle cell disease Data from the study were published online in Blood, a peer-reviewed publication of the American Society of Hematology. GBT intends to submit an NDA for voxelotor under an accelerated approval pathway to the FDA later this year. BTW, Asymmetric, always appreciate your help here. Thank you, t |
return to message board, top of board |